Greater Supply-Chain Transparency Through Data-Based Processes
Pharmaceutical company with volatile demand and inventory planning
Volatile planning and a lack of transparency over inventory led to inefficiencies and risks for the supply chain.
The challenge
The situation
Volatile planning and a lack of transparency over inventory led to inefficiencies and potential disruptions in the supply chain. A streamlined, data-consistent process was needed to pre-empt stock shortages and product destructions.
Our approach
What we delivered
End-to-end mapping of the supply-chain processes, because the volatile planning only became visible once the flows had been recorded throughout.
Introduction of dashboards for continuous inventory transparency, against the two consequences of the missing view: stock shortages and product write-offs.
Gap assessment to surface weaknesses in operations
The outcome
Results & impact
No stock shortages
Avoidance of stock shortages through improved transparency and planning.
No product destructions
Prevention of product destructions through consistent inventory management.
Consistent data
End-to-end data consistency across operations.
In summary
The company has continuous transparency over its inventory and operations and has laid the foundation to permanently avoid shortages and product destructions.
Related expertise
Reporting & Dashboards →
The case study centers on introducing real-time dashboards with clearly defined KPIs for better transparency and faster decisions.
Supply Chain Management →
The case study directly addresses volatile planning and a lack of inventory transparency, core topics of supply-chain management for stable supply.
Digitalization in Life Sciences →
A central focus of the project was integrating digital solutions to increase transparency and data consistency in the pharma supply chain.
Manufacturing & Supply Chain Management →
The comprehensive mapping of the supply-chain processes and the safeguarding of delivery capability match exactly this end-to-end topic area.
Similar projects
More on Pharma →
Sources
- Entourage project experience (anonymised)
Your project
A comparable project?
Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.
Prefer direct? +49 89 4161170-0
info@theentourage.de
- Reply usually within one working day
- 4 offices: DE · CH · IT · US
- 100% life sciences